CytoDyn Inc.

CYDY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Nov 17, 2026 8-K
4 Oct 20, 2026 4
DEFA14A Oct 19, 2026 DEFA14A
8-K Oct 19, 2026 8-K
10-Q Oct 14, 2026 10-Q
EFFECT Oct 7, 2026
424B3 Oct 7, 2026 424B3
EFFECT Oct 2, 2026
EFFECT Oct 2, 2026
DEF 14A Sep 28, 2026 DEF 14A
S-3 Sep 25, 2026 S-3
POS AM Sep 25, 2026 POS AM
POS AM Sep 25, 2026 POS AM
10-K Aug 31, 2026 10-K
EFFECT May 20, 2026
424B3 May 20, 2026 424B3
D May 11, 2026
8-K Apr 30, 2026 8-K
S-1 Apr 22, 2026 S-1
424B3 Apr 8, 2026 424B3
10-Q Apr 8, 2026 10-Q
424B3 Mar 25, 2026 424B3
4 Mar 24, 2026 OWNERSHIP DOCUMENT
4 Mar 24, 2026 OWNERSHIP DOCUMENT
4 Mar 24, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 57 · 1402 filings Older →